本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

35.50
+2.066.16%
成交量:28.67萬
成交額:998.81萬
市值:10.85億
市盈率:-54.27
高:35.69
開:33.64
低:33.64
收:33.44
52周最高:44.28
52周最低:17.72
股本:3,054.95萬
流通股本:2,821.96萬
量比:1.49
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
淨資產收益率:-4.20%
總資產收益率:-1.36%
市淨率:2.31
市盈率(LYR):-42.59

資料載入中...

2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/13

SEC問詢函

Form CORRESP - Correspondence
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities